Psoriasis : : new research / / edited by Shahin Aghaei.

Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some c...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:London : : IntechOpen,, 2022.
©2022
Year of Publication:2022
Language:English
Physical Description:1 online resource (xii, 198 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603626204498
ctrlnum (CKB)5580000000514304
(NjHacI)995580000000514304
(EXLCZ)995580000000514304
collection bib_alma
record_format marc
spelling Psoriasis : new research / edited by Shahin Aghaei.
London : IntechOpen, 2022.
©2022
1 online resource (xii, 198 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics.
1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
Dermatology.
Psoriasis.
1-80355-377-4
Aghaei, Shahin, editor.
language English
format eBook
author2 Aghaei, Shahin,
author_facet Aghaei, Shahin,
author2_variant s a sa
author2_role TeilnehmendeR
title Psoriasis : new research /
spellingShingle Psoriasis : new research /
1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
title_sub new research /
title_full Psoriasis : new research / edited by Shahin Aghaei.
title_fullStr Psoriasis : new research / edited by Shahin Aghaei.
title_full_unstemmed Psoriasis : new research / edited by Shahin Aghaei.
title_auth Psoriasis : new research /
title_new Psoriasis :
title_sort psoriasis : new research /
publisher IntechOpen,
publishDate 2022
physical 1 online resource (xii, 198 pages) : illustrations
contents 1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.
isbn 1-80355-377-4
callnumber-first R - Medicine
callnumber-subject RL - Dermatology
callnumber-label RL321
callnumber-sort RL 3321 P767 42022
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.526
dewey-sort 3616.526
dewey-raw 616.526
dewey-search 616.526
work_keys_str_mv AT aghaeishahin psoriasisnewresearch
status_str n
ids_txt_mv (CKB)5580000000514304
(NjHacI)995580000000514304
(EXLCZ)995580000000514304
carrierType_str_mv cr
is_hierarchy_title Psoriasis : new research /
author2_original_writing_str_mv noLinkedField
_version_ 1796653242650722304
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02114nam a2200313 i 4500</leader><controlfield tag="001">993603626204498</controlfield><controlfield tag="005">20230702034823.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230702s2022 enka o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5580000000514304</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995580000000514304</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995580000000514304</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RL321</subfield><subfield code="b">.P767 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.526</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Psoriasis :</subfield><subfield code="b">new research /</subfield><subfield code="c">edited by Shahin Aghaei.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 198 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Psoriasis is a chronic skin disease that starts with lesions that appear red, thick, scaly, and itchy with bilateral and symmetrical distribution. The lesions are most often seen in the scalp, elbows, knees, and genitalia. The extent of the lesions is not always limited to these areas, and in some cases, it may involve larger parts of the skin, as well as nails and joints in some cases. This book presents a comprehensive overview of psoriasis, including clinical aspects, differential diagnosis by dermoscopic devices, comorbidities, immune system changes, methotrexate therapy, and topical innovative molecular targeted therapeutics.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. The Clinical Characteristics and Treatment Status of Psoriatic Arthritis -- 2. Dermoscopic Differential Diagnosis of Psoriasis -- 3. Psoriasis and Skin Comorbidities -- 4. Th17/IL-17, Immunometabolism and Psoriatic Disease: A Pathological Trifecta -- 5. Immune Markers in Psoriasis -- 6. Immunomodulatory Effect of Methotrexate Abruptly Controls Keratinocyte Activation in Psoriasis -- 7. Topical Moisturisers for the Management of Psoriasis Vulgaris -- 8. Developing Novel Molecular Targeted Therapeutics for Topical Treatment of Psoriasis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Dermatology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Psoriasis.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-377-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aghaei, Shahin,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:13:33 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-02-11 21:29:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5343023870004498&amp;Force_direct=true</subfield><subfield code="Z">5343023870004498</subfield><subfield code="b">Available</subfield><subfield code="8">5343023870004498</subfield></datafield></record></collection>